Prixa, an Indonesia-based healthcare startup has $3 million in investment led by MDI Ventures and the Trans-Pacific Technology Fund (TPTF), along with existing investors Siloam Hospitals Group. After the latest round of investments, Prixa has raised $4.5 million since its launch in 2019.
The company will be using the funding to upscale its platform and user base while supporting its business-to-business (B2B) customer base. Additionally, using the company’s platform, users can directly connect to their primary care services like teleconsultation, pharmacy delivery and on-demand lab testing.
Prixa initially began as an artificial intelligence-based health management platform that delivers telemedicine and other primary care services to the healthcare payers like insurance companies, corporations and government entities. Currently, the company has around 10 million users that range from insurance and corporate members. The healthcare startup is also popular among people for increasing patient satisfaction by delivering fast and usable teleconsultation service.
Prixa chief executive and co-founder James Roring told the media, “There exists a dichotomy in healthcare that there’s constant innovation in the advanced treatment of patients, but access to basic healthcare services continues to lag, particularly in Indonesia.” He added saying that the company’s platform was primarily developed to access the most basic healthcare services with the help of technology. Currently, the company’s platform includes a health assistant that helps answer patients’ questions. The usage of the health assistant was observed to be increased during the Covid-19 pandemic.